HK1000276A1 - Use of bilobalide and derivatives thereof for treating an infection in an individual and pharmaceutical compositions adapted for such use - Google Patents

Use of bilobalide and derivatives thereof for treating an infection in an individual and pharmaceutical compositions adapted for such use

Info

Publication number
HK1000276A1
HK1000276A1 HK97101825A HK97101825A HK1000276A1 HK 1000276 A1 HK1000276 A1 HK 1000276A1 HK 97101825 A HK97101825 A HK 97101825A HK 97101825 A HK97101825 A HK 97101825A HK 1000276 A1 HK1000276 A1 HK 1000276A1
Authority
HK
Hong Kong
Prior art keywords
bilobalide
infection
treating
individual
derivatives
Prior art date
Application number
HK97101825A
Other languages
English (en)
Inventor
Bombardelli Ezio
Ghione Mario
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of HK1000276A1 publication Critical patent/HK1000276A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK97101825A 1992-02-13 1997-09-24 Use of bilobalide and derivatives thereof for treating an infection in an individual and pharmaceutical compositions adapted for such use HK1000276A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929202993A GB9202993D0 (en) 1992-02-13 1992-02-13 Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use

Publications (1)

Publication Number Publication Date
HK1000276A1 true HK1000276A1 (en) 1998-02-20

Family

ID=10710286

Family Applications (1)

Application Number Title Priority Date Filing Date
HK97101825A HK1000276A1 (en) 1992-02-13 1997-09-24 Use of bilobalide and derivatives thereof for treating an infection in an individual and pharmaceutical compositions adapted for such use

Country Status (13)

Country Link
US (1) US5264216A (es)
EP (1) EP0556051B1 (es)
JP (1) JP3156212B2 (es)
KR (1) KR100251394B1 (es)
AT (1) ATE152911T1 (es)
CA (1) CA2089309C (es)
DE (1) DE69310565T2 (es)
DK (1) DK0556051T3 (es)
ES (1) ES2103422T3 (es)
GB (1) GB9202993D0 (es)
GR (1) GR3023414T3 (es)
HK (1) HK1000276A1 (es)
SG (1) SG48723A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379714B1 (en) 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
US6036696A (en) 1997-12-19 2000-03-14 Stryker Technologies Corporation Guide-pin placement device and method of use
AU2006227622A1 (en) * 2005-03-17 2006-09-28 Smith & Nephew, Inc. Medical securing member placement system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3338995A1 (de) * 1983-10-27 1985-05-09 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe Bilobalid enthaltende arzneimittel
IT1238684B (it) * 1990-02-09 1993-09-01 Indena Spa Derivati del bilobalide,loro usi e formulazioni che li contegono

Also Published As

Publication number Publication date
ES2103422T3 (es) 1997-09-16
GB9202993D0 (en) 1992-03-25
GR3023414T3 (en) 1997-08-29
EP0556051A1 (en) 1993-08-18
DE69310565T2 (de) 1997-12-18
SG48723A1 (en) 1998-05-18
JPH0624974A (ja) 1994-02-01
JP3156212B2 (ja) 2001-04-16
EP0556051B1 (en) 1997-05-14
DK0556051T3 (da) 1997-07-28
CA2089309A1 (en) 1993-08-14
CA2089309C (en) 2004-11-30
KR100251394B1 (ko) 2000-05-01
US5264216A (en) 1993-11-23
DE69310565D1 (de) 1997-06-19
KR930017577A (ko) 1993-09-20
ATE152911T1 (de) 1997-05-15

Similar Documents

Publication Publication Date Title
EP0513702A3 (en) Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication
ATE144704T1 (de) Mittel zur topischen verabreichung von arzneiwirkstoffen
MY118371A (en) Tetrahydrolipstatin containing compositions
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
MY105121A (en) Pharmaceutical composition for systemic transdermal administration.
TR199900413T2 (xx) �laca diren�li streptokoklar�n neden oldu�u pn�moni (pn�mokok) tedavisi i�in bir ila� yap�m�nda bir amoksisilin ve klavulanat kombinasyonunun kullan�m�.
DE69307977D1 (de) Stabilisierte Derivate von Vitamin D2 und D3 enthaltende pharmazeutische Zusammensetzungen
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
IT1235153B (it) Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
DE69322251D1 (de) Medizinische zusammensetzung
ITRM910002A1 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
DK0437294T3 (da) Orale farmaceutiske præparater i enhedsdosisform
GR3023414T3 (en) Use of bilobalide and derivatives thereof for treating an infection in an individual and pharmaceutical compositions adapted for such use
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel
MX9400215A (es) Compuestos farmaceuticos.
IT1272762B (it) Derivati benz/e/indenici farmaceuticamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
IT1249060B (it) Composizione farmaceutica ad uso topico per il trattamento di cicatrizzazione e riepitelizzazione di ulcere flebostatiche croniche.
ES2135424T3 (es) Composicion oral a base de ibuprofeno.
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi
EP1250926A3 (en) Use of a water-insoluble S-camptothecin with a closed lactone ring in the manufacture of a medicament for treatment of colon cancer
NO920719L (no) Injiserbare s-adenosyl-l-metionin-holdige preparater
ITMI931598A1 (it) Uso terapeutico della fosfocreatina

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20070212